期刊文献+

难治性高血压及其非介入治疗进展 被引量:7

Progress of Resistant Hypertension and Its Non-interventional Therapy
下载PDF
导出
摘要 难治性高血压一直是心血管专家关注的重点。其概念和定义存在着争议,但由于难治性高血压发病的人群、病因、病理生理学机制和预后存在特殊性,虽然它是一个治疗学概念,但各大指南认为临床应该给予难治性高血压足够的重视,以达到对高血压患者更加全面的控制和靶器官保护。现针对难治性高血压及其非介入治疗方法的进展进行简要综述。 Resistant hypertension has always been the focus of cardiologists.Its concept and definition are controversial,but the population,pathogeny,pathophysiology mechanism and prognosis of resistant hypertension are special.Although it is a therapeutic concept,the major guidelines suggest that cardiologists should pay more attention on resistant hypertension,in order to achieve more comprehensive control and target organ protection for hypertensive patients.This article briefly reviews the progress of resistant hypertension and its non-interventional therapy.
作者 王引利 WANG Yinli(Chengdu Cardiovascular Disease Research Institute, Chengdu 610031, Sichuan, Chin)
出处 《心血管病学进展》 CAS 2018年第5期823-827,共5页 Advances in Cardiovascular Diseases
关键词 难治性高血压 螺内酯 肾素-血管紧张素-醛固酮受体 血管肽酶抑制剂 Resistant hypertension Spironolactone Renin angiotensin aldosterone receptor Angiopeptidase inhibitor
  • 相关文献

参考文献1

二级参考文献25

  • 1Calhoun DA, Jones D,Textor S,et al. Resistant hypertension:diagnosis, evaluation? and treatment. A scientific statement fromthe American Heart Association professional education committeeof the council for high blood pressure research[J]. Hypertension,2008,51(6):1403-1419.
  • 2Chobanian AV, Bakris GL, Black HR* et al; Joint national com-mittee on prevention,detection, evaluation, and treatment ofhigh blood pressure. National heart, lung, and blood institute;National high blood pressure education program coordinating com-mittee. Seventh report of the joint national committee on preven-tion, detection, evaluation, and treatment of high blood pressure[J]. Hypertension,2003,42(6) : 1206-1252.
  • 3Dahlof B,Sever PS, Poulter NR, et al. ASCOT Investigators.Prevention of cardiovascular events with an antihypertensive regi-men of amlodipine adding perindopril as required versus atenololadding bendroflumethiazide as required, in the Anglo-Scandinavi-an cardiac outcomes trial-blood pressure lowering arm(ASCOT-BPLA) : a multicentre andomized controlled trial[J].Lancet,2005,366(9489) :895-906.
  • 4Jamerson K, Weber MA, Bakris GL, et al. ACCOMPLISH trialinvestigators. Benazepril plus amlodipine or hydrochlorothiazidefor hypertension in high-risk patients[J]. N Engl J Med,2008,359(23):2417-2428.
  • 5Schmieder RE!, Redon J,Grassi G, et al. ESH position paper:renal denervation-an interventional therapy of resistant hyperten-sion[J]. J Hypertens,2012,30(5) :837-841.
  • 6Tsioufis C, Kordalis A,Flessas D,et al. Pathophysiology of re-sistant hypertension: the role of sympathetic nervous system[J].Int J Hypertens,2011 ;2011 :642416.
  • 7Barajas L,Liu L, Powers K. Anatomy of the renal innervation:intrarenal aspects and ganglia of origin [J]. Can J PhysiolPharmacol,1992,70(5) :735-749.
  • 8Hering D, Mahfoud F,Walton AS,et al. Renal denervation inmoderate to severe CKD[J]. J Am Soc Nephrol, 2012? 23 (27):1250-1257.
  • 9Laurent S,Schlaich M, Esler M. New drugs, procedures, anddevices for hypertension[J], Lancet,2012,380(9841) :591-600.
  • 10Aucott L,Poobalan A,Smith WC, et al. Effects of weight loss inoverweight/obese individuals and long-term hypertension outcomes : asystematic review[J], Hypertension,2005,45(6) : 1035-1041.

共引文献152

同被引文献58

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部